AsclepiX Therapeutics
Latest round
- Series A
Last raised
- Jul 2023
Total raised
- $20M
Investors
- 4
About AsclepiX Therapeutics
AsclepiX Therapeutics, Inc.Founded in 2011 in Baltimore, US, AsclepiX Therapeutics, Inc. specializes in innovative treatments for ocular diseases.AsclepiX Therapeutics specializes in the development of innovative therapies for ocular diseases, focusing on their lead product, AXT107. This therapeutic candidate inhibits the pro-angiogenic vascular endothelial growth factor receptor 2 (VEGFR2) and activates the vessel stabilizing receptor tyrosine kinase (Tie2), addressing critical pathways in retinal vascular disease treatment.AsclepiX Therapeutics generates revenue through the clinical development and potential commercialization of its therapeutic candidates, with a focus on AXT107. The funds will facilitate the evaluation of AXT107's effectiveness against wet AMD, further solidifying the company's commitment to addressing unmet medical needs in this area.
Who invested in AsclepiX Therapeutics
4 investors across 2 rounds
See all investors in AsclepiX Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AsclepiX Therapeutics
Who invested in AsclepiX Therapeutics?
AsclepiX Therapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AsclepiX Therapeutics raised?
AsclepiX Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AsclepiX Therapeutics last raise money?
AsclepiX Therapeutics's most recent round on record is a Series A, in Jul 2023.
What does AsclepiX Therapeutics do?
AsclepiX Therapeutics is a biotechnology company.
Where is AsclepiX Therapeutics headquartered?
AsclepiX Therapeutics is headquartered in Baltimore, US.
Which VCs invest in companies like AsclepiX Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AsclepiX Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like AsclepiX Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.